Replies to post #90058 on DD Support Board and Research Team

[samsamsamiam]

Made me look! Ampligen
http://www.drugs.com/history/ampligen.html

Do you have a link to the orphan drug status?

but not approved by the FDA here - right?

BTW - threats like that always make the stock look scammy - just sayin'
worry more about what the company says and not some messageboard poster.
hopefully people invest with company filings and what the company says and not some anonymous poster.

[sidedraft]

What is the date of "just got designated"?

[shajandr]

I'm an attorney also - and one with a hell of a lot of experience - more years practicing law than you've been alive. And I am in California - I suggest you investigate our anti-SLAPP law before you digg a Hole™.

Ampligen's a joke. Always has been. I've been in this biz for DECADES - and Ampligen has been around since the '60s and never FDA approved for ANY indication.

The effect noted for administering bulk RNA is OLD and obsolete.

Catch up on real science that's also over a decade old now but is light years more modern and relevant than the stupid Ampligen crapola.

One can START here: https://en.wikipedia.org/wiki/CpG_Oligodeoxynucleotide

and here http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108434/

and yes, not only am I an attorney - I'm a well-published scientist and I've been in the biotech biz for DECADES.

So this is my educated opinion: Ampligen is a joke and will never be licensed for any indication in the USA - ever.

Now, get that SLAPP complaint boilerplate cranked up. I can't wait. I am berry good friends with the first legal counsel the EFF ever had.

Back when some people were in diapers or playing with blocks. Or believing in 5 decade old crapola being spun by Willy Carter.

Can you tell me how many shares (in net dollar proceeds) William Carter has SOLD in HEB since the 1980s?

Not bad for 3 decades of producing NOTHING but shares of HEB stock. And selling them - and taking a huge salary too.

He's made many, many millions for producing NOTHING.

http://www.marketwatch.com/investing/stock/heb/insiders?pid=59796

When you can go back into the '80s and '90s and tell me how many HEB shares Willy Carter has personally SOLD and for how much net personal profit AND his accumulated salary and bonuses from back since the inception of HEB:

THEN we can discuss the issue of whether HEB is a tech stock SCAM.

I strongly believe it is nothing but William A Carter's personal enrichment scheme. And I've followed this HEB crapola since the early '90s.

[236T568]

How is that SLAPP success rate going?


http://www.citronresearch.com/stocklemon-reports-on-hemispherx-biopharma-amex-heb/

Motley Fool writer Bill Mann said it best about Hemispherx when he wrote,” There are a few companies I follow simply because I can not believe that people invest in them.” There is nothing that Stocklemon can write that has not been established by famed short seller Manuel Asensio in his many reports on Hemispherx Biopharma that date back to 1998. Hemispherx went as far as to sue Asensio in a Philadelphia court, a case which Hemispherx lost in February of 2002.

http://www.asensio.com/HemispherxBiopharma/HebIndex.htm

Please check your facts before posting false info that may be detrimental to shareholders' interests. I am large shareholder of HEB and an attorney, and I am not afraid to pursue legal recourse against those spreading false information about this company.

[Risicare]

Tell us more, we love a good laugh here.

[lucky, mydog]

lolol. that's funny.

[DragonBear]

The "failed drug" you refer to (Ampligen)

just got designated as an orphan drug to treat Ebola by the European Medicines Agency.

Which means it now gets to undergo clinical trials. Where "failed drug" is still a possibility. Pretending that Ampligen is a "successful" drug on the cusp of being marketed just because it has EMA orphan status, is rather misleading for HEB or anyone else to state.

HEB can cackle all it wants to about 10 yrs exclusive marketing rights, trying to light up "$" signs in the eyes of investors. It's not going to market anything until EMA approval is given to market the drug. And that will come after HEB initiates, and successfully completes clinical trials. Where is there an announced clinical trial for Ampligen in humans? There seems to be none.